Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Targeted MEK Inhibition in Patients with Previously Treated Multiple Myeloma

Christoph Heuck, MD, Yogesh Jethava, MB, MRCP, MD FRCPath, Rashid Z Khan, MD, Scott Miller, Alan Mitchell, Donald Johann, MD MS, Kelly Robbins, Ryan K Van Laar, PhD, Siraj Ali, MDPhD, Vincent A. Miller, MD, Clyde Bailey, Jeffery Sawyer, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Faith E Davies, MD, Gareth J Morgan, MD PhD, Bart Barlogie, MD, PhD

Blood (2014) 124 (21): 4775.

https://doi.org/10.1182/blood.V124.21.4775.4775

Published: 2014

Journal Articles

Characterization of the Mutational Landscape of Multiple Myeloma Using Comprehensive Genomic Profiling

Christoph Heuck, MD, Donald Johann, MD MS, Brian A Walker, PhD, Caleb K Stein, MS, Yogesh Jethava, MB, MRCP, MD FRCPath, Rashid Z Khan, MD, Scott Miller, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Ruslana Tytarenko, Phillip Farmer, Ryan Williams, Siraj Ali, MDPhD, Phil J Stephens, PhD, Vincent A. Miller, MD, Gareth J Morgan, MD PhD, Bart Barlogie, MD PhD

Blood (2014) 124 (21): 3418.

https://doi.org/10.1182/blood.V124.21.3418.3418

Published: 2014

Journal Articles

Effect Of Low Dose Bortezomib On Bone Formation In Smoldering Myeloma Patients

Maurizio Zangari, MD, Tamara Berno, MD, Mohamed E Salama, MD, Sherjeel Sana, MD, Giampaolo Talamo, MD, Karen Pena, Scott Miller, PhD, Fenghuang Zhan, MD&PhD

Blood (2013) 122 (21): 3204.

https://doi.org/10.1182/blood.V122.21.3204.3204

Published: 2013

Journal Articles

Skeletal-Targeted, Osteolytic-Responsive Drug Delivery System Improves Anti-Tumor Efficacy in Multiple Myeloma.

Xuli Wang, PhD, Ye Yang, PhD, Scott Miller, PhD, Fenghuang Zhan, MD, PhD

Blood (2012) 120 (21): 3155.

https://doi.org/10.1182/blood.V120.21.3155.3155

Published: 2012

Journal Articles

Refining Th Predictive Value of Secretory Phospholipase A2 In Sickle Cell Disease Patients with Acute Chest Syndrome

Lori Styles, MD, Carrie Greene Wager, PhD, Richard J. Labotka, MD, MS, Kim Smith-Whitley, MD, Alexis A. Thompson, MD, MPH, Peter A. Lane, JR, MD, Lillian McMahon, MD, Robin Miller, MD, Susan D. Roseff, MD, Dianne Gallagher, Rathi V. Iyer, MD, Scott Miller, MD

Blood (2010) 116 (21): 846.

https://doi.org/10.1182/blood.V116.21.846.846

Published: 2010

Journal Articles

Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes

Carlton Dampier, MD, Wally R. Smith, MD, Carrie Wager, Margaret Bell, James R. Eckman, MD, Lewis L Hsu, MD, PhD, Donna McClish, PhD, Sonja McKinlay, PhD, Caterina Minitti, MD, Robert Molokie, MD, Kim Smith-Whitley, MD, Marilyn J. Telen, MD, Debra Weiner, MD, PhD, Scott Miller, MD

Blood (2010) 116 (21): 2667.

https://doi.org/10.1182/blood.V116.21.2667.2667

Published: 2010

Journal Articles

Lenalidomide and Rituximab Are a Promising Combination in Vitro, in Vivo Preclinically and in a Phase I/II Clinical Trial in Relapsed/Refractory Mantle Cell Lymphoma

Michael Wang, MD, Liang Zhang, PhD, Luis Fayad, MD, Fredrick Hagemeister, MD, Sattva Neelapu, MD, Felipe Samaniego, M.D., Barbara Pro, MD, Anas Younes, MD, Scott Miller, Robert D. Knight, MD, Jerome B. Zeldis, MD, Qing Yi, MD, PhD, Jorge Romaguera, MD

Blood (2008) 112 (11): 3058.

https://doi.org/10.1182/blood.V112.11.3058.3058

Published: 2008

Journal Articles

TCD in Infants: A Report from the BABY HUG Trial.

Robert J. Adams, Julio Barredo, Duane R. Bonds, Clark Brown, James Casella, Li Daner, A.Russell Gerber, Rathi Iyer, Judy Luden, Scott Miller, Caterina Minniti, Sohail Rana, Renee Rees, Zora Rogers, Stuart Toledano, Winfred Wang, Russell Ware, Sherri Zimmerman

Blood (2005) 106 (11): 952.

https://doi.org/10.1182/blood.V106.11.952.952

Published: 2005

Journal Articles

Evaluation of Chronic Transfusion (Tx) Practices in Children with Sickle Cell Disease (SCD): A Survey of STOP II Investigators.

Ofelia Alvarez, Scott Miller, Brian Berman, Clark Brown, James Casella, Thomas Coates, Charles Daeschner, Beatrice Files, Janet Kwiatkowski, Margaret Lee, Winfred Wang, Gerald Woods

Blood (2004) 104 (11): 3732.

https://doi.org/10.1182/blood.V104.11.3732.3732

Published: 2004

NARROW

Targeted MEK Inhibition in Patients with Previously Treated Multiple Myeloma

Characterization of the Mutational Landscape of Multiple Myeloma Using Comprehensive Genomic Profiling

Effect Of Low Dose Bortezomib On Bone Formation In Smoldering Myeloma Patients

Skeletal-Targeted, Osteolytic-Responsive Drug Delivery System Improves Anti-Tumor Efficacy in Multiple Myeloma.

Refining Th Predictive Value of Secretory Phospholipase A2 In Sickle Cell Disease Patients with Acute Chest Syndrome

Initial Experience with the IMPROVE Trial-a Phase III Analgesic Trial for Hospitalized Sickle Cell Painful Episodes

Lenalidomide and Rituximab Are a Promising Combination in Vitro, in Vivo Preclinically and in a Phase I/II Clinical Trial in Relapsed/Refractory Mantle Cell Lymphoma

TCD in Infants: A Report from the BABY HUG Trial.

Evaluation of Chronic Transfusion (Tx) Practices in Children with Sickle Cell Disease (SCD): A Survey of STOP II Investigators.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only